ANASTASIYA UHLENHOPP: Open Payments
NPI 1164947271 · ALTAMONTE SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 37 payments from 12 companies in 2025. Trend: 2023 $589 · 2024 $235 · 2025 $706
Food & beverage: $679Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $135 |
| Corium, LLC | 6 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Bausch Health US, LLC | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
Products named: VRAYLAR, Azstarys, REXULTI, CAPLYTA, FANAPT, INGREZZA, Auvelity, COBENFY.
Industry payments across FL — which companies pay providers there.
